Holen Sie sich die Stockscreener-App
17.50
1.35%
-0.24
Schlusskurs vom Vortag:
$17.74
Offen:
$17.56
24-Stunden-Volumen:
323.58K
Relative Volume:
6.03
Marktkapitalisierung:
$825.55M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-0.68%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$16.50
$18.43
1-Wochen-Bereich:
$16.50
$18.43
52-Wochen-Spanne:
$16.41
$18.43
Odyssey Therapeutics Inc Stock (ODTX) Company Profile
Firmenname
Odyssey Therapeutics Inc
Sektor
Branche
Telefon
-
Adresse
-
Compare ODTX vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ODTX
Odyssey Therapeutics Inc
|
17.50 | 836.87M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.03B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.88 | 67.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.46 | 50.76B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.45 | 40.12B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
151.56 | 32.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Odyssey Therapeutics Inc Aktie (ODTX) Neueste Nachrichten
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Odyssey Therapeutics hits $900M valuation in Nasdaq debut, stock climbs 13% before diving lower - MSN
IPO Tracker 2026: Parabilis follows hefty Regeneron deal with IPO push - BioSpace
Odyssey Therapeutics (ODTX) Stock Analysis Report | Financials & Insights - Benzinga
Simeon George Discloses Investment at Odyssey Therapeutics with 8.0% Stake - TradingView
SR One funds disclose 8% Odyssey Therapeutics (ODTX) stake after IPO - Stock Titan
TPG funds take 7.8% Odyssey Therapeutics (ODTX) stake via $25M share purchase - Stock Titan
Odyssey Therapeutics (ODTX) 10K Form and Latest SEC Filings 2026 - MarketBeat
Odyssey Therapeutics (ODTX) Stock Chart and Price History 2026 - MarketBeat
Dimension Management Discloses Investment at Odyssey Therapeutics with 7.1% Stake - TradingView
Jeito II S.L.P. Discloses Investment in Odyssey Therapeutics with 7.8% Stake - TradingView
What is the current Price Target and Forecast for Odyssey Therapeutics, Inc. (ODTX) - Zacks Investment Research
Immunology drug developer Odyssey seeks US IPO again - MSN
Immune system biotech odyssey seeks $238.3 million in US IPO - MSN
ODTX Stock Chart | ODYSSEY THERAPEUTICS INC (NASDAQ:ODTX) - ChartMill
Odyssey Therapeutics Prices $304 Million Upsized IPO and Concurrent Private Placement - Global Legal Chronicle
Odyssey Therapeutics (ODTX) Stock Trends and Sentiment 2026 - MarketBeat
ODTX Price History for Odyssey Therapeutics Stock - Barchart.com
ODYSSEY THERAPEUTICS INC (ODTX) - Minichart
Major Investor Quietly Makes a Massive New Bet on Odyssey Therapeutics - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
ODTX | Odyssey Therapeutics, Inc. Common Insider Trading - Quiver Quantitative
Major Insider Move Signals Growing Confidence in Odyssey Therapeutics - TipRanks
ODTX News Today | Why did Odyssey Therapeutics stock drop today? - MarketBeat
Total assets of Odyssey Therapeutics, Inc. – NASDAQ:ODTX - TradingView
Odyssey Therapeutics, Inc. Statistics – NASDAQ:ODTX - TradingView
ODTX Stock Price, Quote & Chart | ODYSSEY THERAPEUTICS INC (NASDAQ:ODTX) - ChartMill
Odyssey Therapeutics, Inc. Dividends – NASDAQ:ODTX - TradingView
Odyssey Therapeutics, Inc. Revenue Breakdown – NASDAQ:ODTX - TradingView
Odyssey Therapeutics, Inc. Earnings and Revenue – NASDAQ:ODTX - TradingView
ODYSSEY THERAPEUTICS INC Statistics – BOATS:ODTX - TradingView
Diluted earnings per share (diluted EPS) of Odyssey Therapeutics, Inc. – NASDAQ:ODTX - TradingView
Odyssey Therapeutics Hits $900M Valuation In Nasdaq Debut, Stock Climbs 13% Before Diving Lower - Stocktwits
ODTX Price Today: Odyssey Therapeutics, Inc. Stock Price, Quote & Chart - MEXC Exchange
Basic earnings per share (basic EPS) of ODYSSEY THERAPEUTICS INC – BOATS:ODTX - TradingView
Non-operating income (total) of ODYSSEY THERAPEUTICS INC – BOATS:ODTX - TradingView
Operating income of Odyssey Therapeutics, Inc. – NASDAQ:ODTX - TradingView
Immunology drug developer Odyssey prices upsized IPO - MSN
Odyssey raises $304 million in upsized Nasdaq debut - The Pharma Letter
ODTX | Odyssey Therapeutics, Inc. Common Institutional Ownership - Quiver Quantitative
ODTX: Odyssey Therapeutics, Inc.Price & EPS Surprise - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Gross Margin (TTM) - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Price - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Gross Profit (TTM) - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Net Income (Quarterly) - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Total Expenses (TTM) - Zacks Investment Research
Dividend HistoryOdyssey Therapeutics, Inc. (ODTX) - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Total Long Term Debt (Quarterly) - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Earnings Yield (TTM) - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Revenue (TTM) - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Enterprise Value - Zacks Investment Research
Finanzdaten der Odyssey Therapeutics Inc-Aktie (ODTX)
Es liegen keine Finanzdaten für Odyssey Therapeutics Inc (ODTX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Odyssey Therapeutics Inc-Aktie (ODTX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Dimension Capital II, L.P. | Director |
May 08 '26 |
Buy |
18.00 |
1,111,111 |
19,999,998 |
3,333,516 |
| SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner |
May 11 '26 |
Buy |
18.00 |
555,555 |
9,999,990 |
1,831,383 |
| SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner |
May 11 '26 |
Sale |
18.00 |
1,780 |
32,040 |
440,981 |
| LEIDEN JEFFREY M | Director |
May 08 '26 |
Buy |
20.00 |
5,000 |
100,000 |
270,198 |
| Haas Jason | Chief Financial Officer |
May 08 '26 |
Buy |
20.00 |
1,000 |
20,000 |
62,908 |
| Li Nan (LN) | Director |
May 11 '26 |
Buy |
18.00 |
1,111,111 |
19,999,998 |
3,333,516 |
| Chu Shelley | Director |
May 11 '26 |
Buy |
18.00 |
11,111 |
199,998 |
11,111 |
2.98%
1.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):